Dr. Frank Matthew Volz Jr., PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 173 West Shore Drive, Pine Plains, NY 12567 Phone: 518-398-5432 Fax: 845-246-3710 |
News Archive
Throughout the world, many medicinal compounds are being discovered. Scientists have learnt to modify the chemical structures of active compounds so that they can improved therapeutic activity and reduced the toxicity.
Just because many businesses are open again doesn't mean the pandemic is over. The coronavirus is still on the loose — actually surging in many locations — which means people have to make serious choices about their health all day, every day.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
There is merit in looking at the use of wearable biosensors to detect whether opioid users stay focused on their rehabilitation programs.
› Verified 8 days ago